Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina    ILMN

ILLUMINA (ILMN)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets
Most relevant news about ILLUMINA
10/19ILLUMINA, INC. : quaterly earnings release
10/16 ILLUMINA : Releases NovaSeq S4 Flow Cell and NovaSeq Xp Workflow
10/10 ILLUMINA : to Announce Third Quarter 2017 Financial Results on Tuesday, October ..
09/07 ILLUMINA : Files New Patent Infringement Suit Against Premaitha Health plc
08/24 ILLUMINA : and Telegraph Hill Partners Launch Verogen, Inc. to Drive Adoption of..
08/22 ILLUMINA : Genomics England Adopts Illumina’s Variant Interpreter for Canc..
08/09 AZUMIO : Introduces DNA-Based Insights into its Fitness Platform
08/08 INSIDER TRADING ACTIVITY ILLUMINA, I : ILMN) – SVP Sold 1,609 shares of St..
08/08 INSIDER TRADING ACTIVITY ILLUMINA, I : ILMN) – EVP Sold 2,000 shares of St..
08/05 INSIDER TRADING ACTIVITY ILLUMINA, I : ILMN) – SVP Sold 10,000 shares of S..
08/05 INSIDER TRADING ACTIVITY ILLUMINA, I : ILMN) – Insider Sold 3,131 shares o..
08/02 Apple, Illumina rise; AMC Entertainment, GGP fall
08/01 ILLUMINA : tops Street 2Q forecasts
08/01 ILLUMINA, INC. (NASDAQ : ILMN) Files An 8-K Results of Operations and Financial ..
08/01 ILLUMINA : Reports Strong Financial Results for Second Quarter of Fiscal Year 20..
More most relevant news
All news about ILLUMINA
10/19 ILLUMINA : to Announce Third Quarter 2017 Financial Results on Tuesday, October ..
10/19ILLUMINA, INC. : quaterly earnings release
10/16 ILLUMINA : Releases NovaSeq S4 Flow Cell and NovaSeq Xp Workflow
10/12 ILLUMINA : Patent Issued for Fluidic System for Reagent Delivery to a Flow Cell ..
10/11 ILLUMINA : purchase of the Illumina Care Advantage Plan to perform routine maint..
10/10 ILLUMINA : to Announce Third Quarter 2017 Financial Results on Tuesday, October ..
10/06 ILLUMINA : D-Notice of Intent to Sole Source - Subscription License Annual Renew..
09/27 ILLUMINA : Annual Service Agreement on Illumina Equiment
09/26 ILLUMINA : MILITARY $159,208 Federal Contract Awarded to Illumina
09/22 ILLUMINA : $19.5 Million Federal Contract Awarded to Illumina
More news
Sector news : Advanced Medical Equipment & Technology - NEC
10/20DJROYAL PHILIPS : Philips Appoints Chief Legal Officer to Management Board
10/17 European shares slip from highs as results, commodities weigh
10/16 Kobe Steel scandal latest to expose 'Made-in-Japan' fault-lines
10/11DJROYAL PHILIPS : Philips to Suspend Production of External Defibrillators at US F..
10/09 LafargeHolcim poaches Essilor's finance chief
10/09DJBOSTON SCIENTIFIC : Health-care Firms Used Radio, Social Media to Find Missing W..
More sector news : Advanced Medical Equipment & Technology - NEC
News from SeekingAlpha
10/17 PacBio Is A DNA Sequencing Standout
10/16 YOUR DAILY PHARMA SCOOP : ACRX Second Chance, AERI Rhopressa Success, Aratana EN..
10/11 Seeking Alpha? Here's Alpha
10/11 Gene Sequencing, The Driver Of Personalized Medicine
10/10 YOUR DAILY PHARMA SCOOP : MannKind Is A Trade Not An Investment; AstraZeneca's I..
10/06 YOUR DAILY PHARMA SCOOP : Gilead, Some History; Biogen's Spinraza, MDCO New Data..
Latest Tweets
10/203 Things to Expect in Illumina's Q3 Earnings Results: Motley Fool  
10/18Sentry Investment Management LLC Holds Stake in Illumina, Inc. $ILMN  
10/17Get the latest news and updates for $CNI $ISRG $ILMN $NMHLY $FNERF automatica.. 
10/17Jay Flatley and John Martin to be Named Recipients of Life Sciences Leadershi..
1
10/17This strikes me as an excellent use of a corp VC - to encourage entreps to fi..
5
More tweets
Qtime:68
Financials ($)
Sales 2017 2 684 M
EBIT 2017 645 M
Net income 2017 792 M
Finance 2017 821 M
Yield 2017 -
P/E ratio 2017 38,97
P/E ratio 2018 51,41
EV / Sales 2017 11,1x
EV / Sales 2018 9,67x
Capitalization 30 705 M
Chart ILLUMINA
Duration : Period :
Illumina Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Technical analysis trends ILLUMINA
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 193 $
Spread / Average Target -8,0%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Ostadan Omead Executive VP-Operations, Products & Strategy
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA60.25%30 705
THERMO FISHER SCIENTIFIC INC.34.10%77 329
DANAHER10.55%63 154
INTUITIVE SURGICAL67.64%41 191
BOSTON SCIENTIFIC CORPORATION36.48%40 738
ROYAL PHILIPS20.29%39 253